217 related articles for article (PubMed ID: 15920699)
21. Extraskeletal myxoid chondrosarcoma: a clinicopathologic, immunohistochemical, and ploidy analysis of 23 cases.
Oliveira AM; Sebo TJ; McGrory JE; Gaffey TA; Rock MG; Nascimento AG
Mod Pathol; 2000 Aug; 13(8):900-8. PubMed ID: 10955458
[TBL] [Abstract][Full Text] [Related]
22. Identification of a novel fusion gene involving hTAFII68 and CHN from a t(9;17)(q22;q11.2) translocation in an extraskeletal myxoid chondrosarcoma.
Attwooll C; Tariq M; Harris M; Coyne JD; Telford N; Varley JM
Oncogene; 1999 Dec; 18(52):7599-601. PubMed ID: 10602520
[TBL] [Abstract][Full Text] [Related]
23. Extraskeletal myxoid chondrosarcoma with a t(9;16)(q22;p11.2) resulting in a NR4A3-FUS fusion.
Broehm CJ; Wu J; Gullapalli RR; Bocklage T
Cancer Genet; 2014 Jun; 207(6):276-80. PubMed ID: 25130955
[TBL] [Abstract][Full Text] [Related]
24. A chondrogenic gene expression signature in mesenchymal stem cells is a classifier of conventional central chondrosarcoma.
Boeuf S; Kunz P; Hennig T; Lehner B; Hogendoorn P; Bovée J; Richter W
J Pathol; 2008 Oct; 216(2):158-66. PubMed ID: 18702172
[TBL] [Abstract][Full Text] [Related]
25. Endothelial cell KIT expression in human tumours.
Sihto H; Tynninen O; Bützow R; Saarialho-Kere U; Joensuu H
J Pathol; 2007 Mar; 211(4):481-8. PubMed ID: 17294421
[TBL] [Abstract][Full Text] [Related]
26. Next generation sequencing of extraskeletal myxoid chondrosarcoma.
Davis EJ; Wu YM; Robinson D; Schuetze SM; Baker LH; Athanikar J; Cao X; Kunju LP; Chinnaiyan AM; Chugh R
Oncotarget; 2017 Mar; 8(13):21770-21777. PubMed ID: 28423517
[TBL] [Abstract][Full Text] [Related]
27. Extraskeletal myxoid chondrosarcoma: combining cytopathology with molecular testing to achieve diagnostic accuracy.
Wakely PE
J Am Soc Cytopathol; 2021; 10(3):293-299. PubMed ID: 32828707
[TBL] [Abstract][Full Text] [Related]
28. Clear cell sarcoma of the kidney: up-regulation of neural markers with activation of the sonic hedgehog and Akt pathways.
Cutcliffe C; Kersey D; Huang CC; Zeng Y; Walterhouse D; Perlman EJ;
Clin Cancer Res; 2005 Nov; 11(22):7986-94. PubMed ID: 16299227
[TBL] [Abstract][Full Text] [Related]
29. The utility of fluorescence in situ hybridization (FISH) in the diagnosis of myxoid soft tissue neoplasms.
Downs-Kelly E; Goldblum JR; Patel RM; Weiss SW; Folpe AL; Mertens F; Hartke M; Tubbs RR; Skacel M
Am J Surg Pathol; 2008 Jan; 32(1):8-13. PubMed ID: 18162764
[TBL] [Abstract][Full Text] [Related]
30. Fluorescence in situ hybridization is a useful ancillary diagnostic tool for extraskeletal myxoid chondrosarcoma.
Wang WL; Mayordomo E; Czerniak BA; Abruzzo LV; Dal Cin P; Araujo DM; Lev DC; López-Terrada D; Lazar AJ
Mod Pathol; 2008 Nov; 21(11):1303-10. PubMed ID: 18587326
[TBL] [Abstract][Full Text] [Related]
31. Fusion of the EWS-related gene TAF2N to TEC in extraskeletal myxoid chondrosarcoma.
Sjögren H; Meis-Kindblom J; Kindblom LG; Aman P; Stenman G
Cancer Res; 1999 Oct; 59(20):5064-7. PubMed ID: 10537274
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential.
Francis P; Namløs HM; Müller C; Edén P; Fernebro J; Berner JM; Bjerkehagen B; Akerman M; Bendahl PO; Isinger A; Rydholm A; Myklebost O; Nilbert M
BMC Genomics; 2007 Mar; 8():73. PubMed ID: 17359542
[TBL] [Abstract][Full Text] [Related]
33. Identification of an Actionable Mutation of KIT in a Case of Extraskeletal Myxoid Chondrosarcoma.
Urbini M; Indio V; Astolfi A; Tarantino G; Renne SL; Pilotti S; Dei Tos AP; Maestro R; Collini P; Nannini M; Saponara M; Murrone L; Dagrada GP; Colombo C; Gronchi A; Pession A; Casali PG; Stacchiotti S; Pantaleo MA
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29937513
[TBL] [Abstract][Full Text] [Related]
34. Fusion of the RBP56 and CHN genes in extraskeletal myxoid chondrosarcomas with translocation t(9;17)(q22;q11).
Panagopoulos I; Mencinger M; Dietrich CU; Bjerkehagen B; Saeter G; Mertens F; Mandahl N; Heim S
Oncogene; 1999 Dec; 18(52):7594-8. PubMed ID: 10602519
[TBL] [Abstract][Full Text] [Related]
35. Molecular analysis of the fusion of EWS to an orphan nuclear receptor gene in extraskeletal myxoid chondrosarcoma.
Brody RI; Ueda T; Hamelin A; Jhanwar SC; Bridge JA; Healey JH; Huvos AG; Gerald WL; Ladanyi M
Am J Pathol; 1997 Mar; 150(3):1049-58. PubMed ID: 9060841
[TBL] [Abstract][Full Text] [Related]
36. Extraskeletal myxoid chondrosarcoma with neuroendocrine differentiation: a pathologic, cytogenetic, and molecular study of a case with a novel translocation t(9;17)(q22;q11.2).
Harris M; Coyne J; Tariq M; Eyden BP; Atkinson M; Freemont AJ; Varley J; Attwooll C; Telford N
Am J Surg Pathol; 2000 Jul; 24(7):1020-6. PubMed ID: 10895826
[TBL] [Abstract][Full Text] [Related]
37. Chromosomal abnormality t(9;22)(q22;q12) in an extraskeletal myxoid chondrosarcoma characterized by fine needle aspiration cytology, electron microscopy, immunohistochemistry and DNA flow cytometry.
Orndal C; Carlén B; Akerman M; Willén H; Mandahl N; Heim S; Rydholm A; Mitelman F
Cytopathology; 1991; 2(5):261-70. PubMed ID: 1782363
[TBL] [Abstract][Full Text] [Related]
38. Extraskeletal myxoid chondrosarcoma of the perineum.
Mavrogenis AF; Patapis P; Papaparaskeva KT; Galanis EC; Papagelopoulos PJ
Orthopedics; 2009 Mar; 32(3):216. PubMed ID: 19309044
[TBL] [Abstract][Full Text] [Related]
39. Applications of tissue microarray technology in immunohistochemistry: a study on c-kit expression in small cell lung cancer.
Donati V; Faviana P; Dell'omodarme M; Prati MC; Camacci T; De Ieso K; Giannini R; Lucchi M; Mussi A; Pingitore R; Basolo F; Fontanini G
Hum Pathol; 2004 Nov; 35(11):1347-52. PubMed ID: 15668891
[TBL] [Abstract][Full Text] [Related]
40. Validation of immature adipogenic status and identification of prognostic biomarkers in myxoid liposarcoma using tissue microarrays.
Cheng H; Dodge J; Mehl E; Liu S; Poulin N; van de Rijn M; Nielsen TO
Hum Pathol; 2009 Sep; 40(9):1244-51. PubMed ID: 19368956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
